US judge overturns earlier implants ruling:
This article was originally published in Clinica
Executive Summary
Women not covered by Dow Corning's $3.2 billion silicone breast implant settlement may not sue the company's joint parents, Dow Chemical and Corning, district judge Denise Page Hood ruled on November 13. Her decision overturned a December 1999 ruling (see Clinica No 890, p 9) and clears the way for claimants to receive compensation. Lawyer Jeff White opposes the latest ruling and says more appeals lie ahead. The settlement amount was reserved for the more than 170,000 women who said the implants provoked various health problems. 94% of the women, who last year voted for a course of action, approved the Dow Corning settlement plan. Dow Corning stopped manufacturing the implants in 1992.
You may also be interested in...
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.